BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund actively managed to deliver high total returns through a diversified portfolio primarily focused on the health sciences sector, encompassing pharmaceuticals, biotechnology, and medical devices. Backed by the expertise of BlackRock, a leading global investment manager, BMEZ capitalizes on the significant growth potential and innovation trends driven by demographic changes and increased healthcare expenditures. With a disciplined investment approach, this fund represents an appealing opportunity for institutional investors seeking to capitalize on the dynamic and evolving landscape of health sciences, thereby enhancing their overall investment strategies.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 0.84 |
| Price-to-Sales (TTM) | 8.84 |
| EV/Revenue | 8.84 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $62.50M |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 21.39% |